期刊文献+

拉帕替尼的合成工艺改进 被引量:1

Improvement of Synthesis Process of Lapatinib
下载PDF
导出
摘要 目的改进拉帕替尼的合成工艺。方法以N-(3-氯-4-((3-氟苯基)甲氧基)苯基)-6-碘喹唑啉-4-胺为原料,经Suzuki偶联,再与对甲苯磺酸成单盐。再经加成,还原,与对甲苯磺酸成双盐。四氢呋喃/水中自然降温,生成拉帕替尼。结果通过熔点测定、HPLC、质谱、1H NMR、元素分析、红外分析、对甲苯磺酸含量和水分含量测定等方法确证目标物结构。结论本工艺操作简单,适合工业化生产。 Objective To improve the synthesis process of lapatinib. Methods With N-(3-chloro-4-((3-fluorobenzyl) oxy)phenyl)-6-iodoquinazolin-4-amine as the starting material, single salt was prepared through reaction with p-toluene sulfonic acid after Suzuki cross-coupling reaction. After addition and reduction reaction, double salt was prepared through reaction with p-toluene sulfonic acid. Lapatinib was obtained by natural cooling in THF/H2O. Results The structure of lapatinib was verified by mp determination, HPLC, MS, 1H NMR, elemental analysis, IR and determination of p-toluene sulfonic acid and water. Conclusion The process is simple, and can be suitable for large- scale production.
出处 《食品与药品》 CAS 2015年第4期244-246,共3页 Food and Drug
关键词 拉帕替尼 工艺 改进 lapatinib process improvement
  • 相关文献

参考文献6

二级参考文献33

  • 1Petrov KG, Zhang YM, Carter M, et al. Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series [J]. Bioorg Med Chem Lett, 2006, 16(17): 4686-4691.
  • 2Soghra K, Didier P, Alexander M, et al. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase [J]. Bioorg Med Chem, 2005, 13 (7) : 2637-2649.
  • 3Balcom D, Furst A. Reductions with hydrazine hydrate catalyzed by Raney nickel. I. Aromatic nitro compounds to amines [J]. J Am Chem Soc, 1953, 75(17): 4334.
  • 4Wissner A, Fraser HL, Ingalls CL, et al. Dual irreversible kinase inhibitors: quinazoline-based inhibitors incoiporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2 [J]. Bioorg Med Chem, 2007, 15(11): 3635-3648.
  • 5Fischer RW, Misun M. Large-scale synthesis of a pyrrolo[2,3-d]pyrimidine via Dakin-West reaction and Dimroth rearrangement [J]. Org Proc Res Dev, 2001, 5 (6) : 581-586.
  • 6Mcclure MS, Osterhout MH, Roschangar F, et al. Quinazoline ditosylate salt compounds: WO, 2002002552[P]. 2002-01-10.
  • 7Abdel-Magid AF, Carson KG, Harris BD, et al. Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride studies on direct and indirect reductive amination procedures [J]. J Org Chem, 1996, 61 (11) : 3849-3862.
  • 8Byung HH, Dae HS, Sung YC. Graphite catalyzed reduction of aromatic and aliphatic nitro compounds with hydrazine hydrate [J]. Tetrahedron Lett, 1985, 26 (50): 6233-6234.
  • 9Liao JJ. Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors [ J ]. J Med Chem,2007,50 ( 3 ) :409 - 424.
  • 10Johnston SRD, Leafy A. Lapatinib:a novel EGFR/HER2 tyrosine kinase inhibitor for cancer[J].Drugs Today,2006,42 (7) : 441 - 453.

共引文献23

同被引文献14

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部